McKesson Corporation (BMV:MCK)

Market Cap	2.03T +33.4%
Revenue (ttm)	7.16T +15.5%
Net Income	78.13B +53.6%
EPS	625.49 +59.2%
Shares Out	n/a
PE Ratio	25.92
Forward PE	22.37
Dividend	58.63 (0.40%)
Ex-Dividend Date	Dec 1, 2025

Volume	n/a
Average Volume	101
Open	14,650
Previous Close	14,650
Day's Range	14,650 - 14,650
52-Week Range	12,403 - 15,725
Beta	0.41
RSI	61.97
Earnings Date	Feb 4, 2026

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialt...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1833
• Employees: 45,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: MCK

Financial Performance

In fiscal year 2025, McKesson's revenue was $359.05 billion, an increase of 16.22% compared to the previous year's $308.95 billion. Earnings were $3.30 billion, an increase of 9.76%.

Financial numbers in USD